Literature DB >> 23678410

Translational researches require effective protocols for knowledge and technology transfer and integration.

Yadollah Omidi1.   

Abstract

Integration of several disciplines (nonclinical, preclinical and clinical researches) during drug discovery and development through learning and confirmation process needs a dynamic process; "translational medicine" (TM) to give a holistic understanding of the entire process. To achieve the highest impacts, however, effective standard protocols need to be performed.

Keywords:  Integrative Research; Technology Transfer; Translational Medicine

Year:  2011        PMID: 23678410      PMCID: PMC3648956          DOI: 10.5681/bi.2011.010

Source DB:  PubMed          Journal:  Bioimpacts        ISSN: 2228-5652


  11 in total

1.  Flow cytometry-based biomarkers in translational medicine and drug development.

Authors:  Virginia Litwin; M R G O'Gorman
Journal:  J Immunol Methods       Date:  2010-10-01       Impact factor: 2.303

2.  Translational medicine: the discovery of bridging biomarkers using pharmacogenomics.

Authors:  Donna L Mendrick
Journal:  Pharmacogenomics       Date:  2006-09       Impact factor: 2.533

Review 3.  What's next in translational medicine?

Authors:  Bruce H Littman; Linda Di Mario; Mario Plebani; Francesco M Marincola
Journal:  Clin Sci (Lond)       Date:  2007-02       Impact factor: 6.124

4.  Translational regenerative medicine research: essential to discovery and outcome.

Authors:  Chris Mason; Peter Dunnill
Journal:  Regen Med       Date:  2007-05       Impact factor: 3.806

5.  Translational models for musculoskeletal tissue engineering and regenerative medicine.

Authors:  Robert L Sah; Anthony Ratcliffe
Journal:  Tissue Eng Part B Rev       Date:  2010-02       Impact factor: 6.389

6.  Proteomics and translational medicine: molecular biomarkers for cancer diagnosis, prognosis and prediction of therapy outcome.

Authors:  William C S Cho
Journal:  Expert Rev Proteomics       Date:  2011-02       Impact factor: 3.940

7.  Integration of Molecular, Cellular and Translational Researches in BioImpacts.

Authors:  Yadollah Omidi
Journal:  Bioimpacts       Date:  2011-06-09

Review 8.  Developing predictive CSF biomarkers-a challenge critical to success in Alzheimer's disease and neuropsychiatric translational medicine.

Authors:  Dorothy G Flood; Gerard J Marek; Michael Williams
Journal:  Biochem Pharmacol       Date:  2011-02-03       Impact factor: 5.858

9.  Ovarian cancer biomarkers for molecular biosensors and translational medicine.

Authors:  K Stephen Suh; Sang W Park; Angelica Castro; Hiren Patel; Patrick Blake; Michael Liang; Andre Goy
Journal:  Expert Rev Mol Diagn       Date:  2010-11       Impact factor: 5.225

10.  Ancestry in translational genomic medicine: handle with care.

Authors:  David Gurwitz; Jeantine E Lunshof
Journal:  Genome Med       Date:  2009-02-25       Impact factor: 11.117

View more
  4 in total

1.  Smart multifunctional theranostics: simultaneous diagnosis and therapy of cancer.

Authors:  Yadollah Omidi
Journal:  Bioimpacts       Date:  2011-09-30

2.  Translational Approaches towards Cancer Gene Therapy: Hurdles and Hopes.

Authors:  Jaleh Barar; Yadollah Omidi
Journal:  Bioimpacts       Date:  2012-09-22

Review 3.  Computerized techniques pave the way for drug-drug interaction prediction and interpretation.

Authors:  Reza Safdari; Reza Ferdousi; Kamal Aziziheris; Sharareh R Niakan-Kalhori; Yadollah Omidi
Journal:  Bioimpacts       Date:  2016-06-16

Review 4.  Transformative dynamism in pharmaceutical and biomedical research: Complexity of integration of innovative R & D hubs.

Authors:  Yadollah Omidi; Hossein Omidian
Journal:  Bioimpacts       Date:  2021-02-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.